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Meihua Piao, Ye Yuan, Yanshu Wang and Chunsheng Feng*Abstract
A case of 65 year-old Chinese male patient with severe tracheal stenosis due to a massive substernal goiter, is
presented. MRI and CT scan revealed that the massive substernal goiter was 9.3 × 6.1 × 4.7 cm in size, displacing the
trachea and adjacent large vessels to the patient’s right contributing to severe intrathoracic trachea compression up
to 6 cm in length and the narrowest caliber of the trachea only 3.0 mm in diameter. To the best of our knowledge,
optimal airway management for the massive substernal goiter resection was considered to be temporary
tracheobronchial stent placement pre-operation.
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Total obstruction of the airway is a life-threatening
complication in patients with severe tracheal stenosis
caused by substernal goiter, which is generally defined
as a thyroid mass that has 50% or more of its volume
located below the thoracic inlet [1], although retrosternal
is probably a more precise term. Substernal goiter may
be detected incidentally on chest x-ray or CT scan or
found because of obstructive symptoms such as dyspnea,
wheezing, or cough. The most common obstructive
symptom is exertional dyspnea, which is present in 30 to
60 percent of cases, and usually occurs when the tracheal
diameter is less than 8 mm. The airway obstruction
can occur during induction of anesthesia, extubation,
surgical resection, or simply by a change of posture.
How to establish a patent airway peri-operation is of
crucial importance and great challenge to the anesthe-
siologist. Herein, a case of severe tracheal stenosis due
to external compression by a massive substernal goiter,
is presented. A temporary endoluminal self-expandable
metallic stent (SEMS) was acquired successfully pre-
operation which was considered the optimal management
to improve the airway obstruction.* Correspondence: fcs1971@hotmail.com
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Case report
A 65-year old, 57 kg weighed Chinese male patient came
to the outpatient clinic complained of anterior neck
swelling and dyspnea. He started to notice his anterior
neck swelling five years ago and it was progressively
increasing in size. During the last four months he
developed aggressive dyspnea, and in the recent two
weeks he presented blue lips (cyanosis) and obvious
obstructive symptoms including shortness of breath,
inspiratory and expiratory stridor in awake, dyspnea
and could not lie in supine completely at all. He was
forced orthopnea at daytime and hardly could he fall
asleep at night except for turning in left lateral decubitus
for a while which he felt better for breathing, but often
awaked due to dyspnea as he fell asleep. He denied of
any underlying medical illness.Examination
On examination, a tumor in the left lobe of thyroid with
the size of 10 × 8 cm could be touched. It extended from
below the chin level until the suprasternal notch and the
inferior margin was not palpable. Magnetic resonance
imaging (MRI) and computed tomography (CT) of the
neck demonstrated a massive elliptical substernal goiter
measuring 9.3 × 6.1 × 4.7 cm, displacing the trachea and
adjacent large vessels to the patient’s right, contributing. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in length and the narrowest caliber of the trachea only
3.0 mm in diameter (D). The trachea should run straight
from the mouth/nose down to the lungs rather than
being curved (outlined in light red) like it is in this picture
(Figure 1). The bronchoscopic examination through
nose showed that the trachea was depressed at 20 cm
from the nostril, and at the level of 25 cm from the
nostril it was narrowed even more seriously so that
the bronchoscope of outer diameter (OD) 2.8 mm could
barely go through with some resistance. The tunica
mucosa bronchiorum was smooth under bronchoscopy.
(Figure 2) This procedure was forced to an end because
of the patient’s obvious apopnixis. Arterial blood gas
analysis (ABGA) showed that pH 7.39, PaCO2 42 mmHg,
PaO2 56 mmHg and SpO2 85% with room air.
Pre-operative airway evaluation revealed Mallampati
score class 2, normal thyromental distance and no limi-
tation of neck or mandible movements. The emphasis of
anesthesia was focused on airway management strategies
for this patient, aimed at relieving airway obstruction
peri-operation. Routine airway management such as
laryngeal mask airway and endotracheal intubation was
impossible for this patient as the narrowest part of the
trachea lied beneath the sternum. Once the tracheal
obstruction occurs, tracheostomy did not seem feasible.
Thus, after meticulous consideration and discussion with
the surgeons, we suggested placement of a tracheobronchial
stent under topical anesthesia be the first choice for
airway obstruction improvement.
Tracheobronchial stent placement
In the interventional radiology suite, topical pharyngeal
anesthesia was started using a standard nebulizer filled
with 3 ml of 1% tetracaine and driven by a flow of 8 L
of oxygen per minute. Topical anesthesia of trachea
mucosa was then performed with 3 ml of 1% tetracaineA 
Figure 1 Magnetic resonance imaging (MRI) (A) and computed tomog
goiter, displacing the trachea and adjacent large vessels to the patien
compression up to 6 cm in length and the narrowest caliber of the trvia thyrocricocentesis by coughing to confirm diffusion
of anesthetic within the trachea. An endoluminal self-
expandable metallic stent, 10 cm in length, is delivered
over a guidewire under fluoroscopic guidance. Fluoro-
scopic result was immediately reviewed as soon as
successful and uneventful placement of the stent, the
caliber of the stenotic trachea was extended to 10 mm
(Figure 3), and the obstructive symptoms improved
immediately, SpO2 increased to 96% with room air.
The day after tracheobronchial stent placement, the
patient was scheduled for thyroidectomy. On arrival at
the operating room, standard monitors including non-
invasive blood pressure (NIBP), electrogram (ECG),
oxygen saturation (SpO2) and end tidal carbondioxide
(ETCO2) were applied. Anesthesia was induced with
midazolam 2 mg, fentanyl 0.3 mg, vecuronium 8 mg
and propofol 120 mg, and a size of inner diameter (ID)
7.0 mm reinforced endotracheal tube (ETT) was inserted
under fibroscopic guidance. Anesthesia was maintained
with intravenous infusion of propofol and remifentanil.
The surgical procedure was uneventful. The ventilator
was weaned off 20 min after the surgery and the patient
was then extubated as his consciousness recovered.
The patient was observed in the post-anesthesia care
unit (PACU) for one hour before he was sent to the
ward. He denied of any discomfort and his SpO2 main-
tained around 95% with room air at PACU. The patient
was discharged home on the seventh post-operative day
and the tracheobronchial stent was removed two months
later without any complication.
Discussion
Tracheobronchial stenosis leading to flow-limiting com-
promise of major airway may result from a heterogeneous
group of disorders including neoplasm, inflammatory
disease, extrinsic compression, tracheomalacia, trauma, and
strictures that can occur after intubation or surgery [2].B
raphy (CT) (B) demonstrated a massive elliptical substernal
t’s right, contributing to severe intrathoracic tracheal
achea (arrows in light red) was about 3.0 mm in diameter.
A B
Figure 2 The bronchoscopic examination through nose showed that the trachea 20 cm from the nostril was depressed (A), and the
site 25 cm from the nostril was narrowed seriously (B) so that the bronchoscope of outer diameter (OD) 2.8 mm could barely go
through with some resistance. The tunica mucosa bronchiorum was smooth under bronchoscopy.
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symptoms ranging from shortness of breath to asphyxi-
ation. Anesthetic management of a patient with a massive
cervico-mediastinal goiter always gives rise to additional
challenges to the anesthesiologist including difficult intub-
ation and tracheal collapse after extubation. Depending on
the severity of trachea stenosis and its location, there may
be a variety of choices for peri-operative airway manage-
ment such as facemask, tracheal intubation tube [3,4],
laryngeal mask airway [5], tracheotomy, cardiopulmo-
nary bypass, and extracorporeal membrane oxygenation
(ECMO) [6]. But these choices seem unfit for this patient.
After team consultation among thoracic, cardiovascular,
thyroid surgeons and anesthesiologists, we decided to
implant a temporary tracheobronchial stent with topical
anesthesia under fluoroscopic guidance at first, and then
perform thyroidectomy surgery with fibroscope guided
reinforced ETT intubation under general anesthesia.A
Before SEMS placement
Figure 3 Before placement of a self-expendable metallic stent (SEMS)
substernal goiter (A). But after placement of a SEMS (B), the stenosis was
extended to 10 mm, and the symptom of dyspnea improved immediately.The anesthetic considerations for patients with a sub-
sternal goiter vary according to the individual anatomy,
pathology and the proposed surgical procedure. Thus,
although there are general principles of secure anesthesia
for these patients, it is imperative to individualize airway
management on a case-by-case basis.
Awake intubation risks endotracheal edema in this
patient as repeat attempts for the ETT passing through
the stenosis are inevitable somehow though. In this
case, even mild edema will lead to fatal airway obstruction.
We should neither choose a usual ETT (ID 7.0-8.0 mm
for adult) for intubation whose narrowest caliber of the
stenotic trachea was 3.0 mm in diameter nor should we
choose a thinner ETT which is insufficient for ventilation.
An alternative method of airway secure is the use of
emergency attempts at tracheostomy impending total
airway obstruction during operation candidate or induc-
tion of anesthesia [7]. This method was ever consideredB  
After SEMS placement
, the trachea was dislocated and seriously compressed by the
improved significantly, the caliber of the stenotic trachea was
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was infeasible to relieve airway obstruction in this
patient because the tracheal stenosis is far below the
site of the tracheotomy orifice.
A same catastrophic situation may arise during induction
of anesthesia. Relaxation of airway smooth muscle with
anesthetic agents further compressed the airway, followed
by inability of ventilation for this patient. What’s the worse,
ETT intubation at this moment is not accessible neither,
contributing to life-threatening airway obstruction.
Wang GS et al. [8] reported thyroidectomy for trachea
compression under extracorporeal circulation. Since car-
diopulmonary bypass and ECMO results in a systemic
inflammatory response syndrome characterized by an
increase in capillary permeability and edematous changes
in trachea and thyroids, bleeding,acute renal dysfunction,
pulmonary incompetence and higher expenses. Its adverse
effects may somehow outweigh the benefits. So if it were
not the optimum, it had to be the last choice.
Airway stents have been most commonly used for
palliation in patients with malignant airway obstruction
(MAO) such as lung and esophageal cancer, thyroid
carcinoma and lymphoma that are not amenable to
surgical or bronchoscopic repair [9-12]. In spite of its
application and durability concerns in patients with
benign disease [2,13], it has been shown increasing
popularity with benign diseases such as tracheal strictures
and tracheobronchomalacia due to large-sized goiter
compressing over the tracheal structures for a long
duration [14-16]. We reported in this case that the ap-
plication of the SEMS aimed at not only improve pre-
operative airway obstruction but also protect the potential
airway collapse from post-operative tracheomalacia.
Placement of endoluminal stent offers a rapid and effect-
ive means of airway patency, thereby leading to dramatic
improvement of symptoms and pulmonary function [17].
It has been documented that after placement of the
tracheobronchial stent, dramatic improvements of life-
threatening dyspnea in 70%–100% of patients with air-
way stenosis can be achieved immediately [18], which
in turn prepare him for the surgery much better. This
is also why we choose temporary SEMSs for this patient of
massive thyroid goitor.
The effect of the stent in adult patients is better than
in pediatric ones, because issues of trachea and pul-
monary in pediatric patients grow gradually, leading to
the possibility of stent removal and replacement [7].
Tracheobronchial stent is indicated in both benign and
malignant airway management, but the most common
indication is malignant stenosis [19-22].
It is reported that complications of airway stent occur
in up to 18% of patients [23,24]. The most common and
serious complications are granulation tissue formation
and secretion obstruction. Other problems associated withstents include migration, malposition, infection, slippage
and bleeding [25]. On the day of operation, we insisted
on ETT intubation under fibroscope guidance to avoid
migration or malposition of the stent. Follow-up of
the patients is mandatory to prevent the formation of
obstructing granulation tissue. These complications did
not appear in this case possibly due to its short-term
duration (only two months).
As mentioned above, tracheobronchial stent placement
may be the optimal choice for the patient and protect
the trachea from potential collapse due to tracheomalacia
by substernal goiter’ s long-term compression after extu-
bation. In this case, we succeeded in alleviating the
tracheal obstruction via tracheobronchial stent and
performed the thyroidectomy uneventfully.
Conclusion
We herein conclude that stent placement with accept-
able complications is a viable option for severe tracheal
stenosis by massive substernal goiter especially for those
who need surgical resection. In some patients this pro-
cedure may be the final or even optimal solution offering
stable short-term or long-term airway stability.
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